Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 55,500 | 56,619 | 63,074 | 61,467 | 60,009 |
| Cost of Goods | 10,083 | 8,997 | 7,624 | 4,981 | 3,972 |
| Gross Profit | 45,417 | 47,622 | 55,450 | 56,486 | 56,037 |
| Operating Expenses | 49,523 | 55,308 | 65,799 | 69,983 | 62,321 |
| Operating Income | -4,106 | -7,686 | -10,349 | -13,497 | -6,284 |
| Interest Expense | 7,093 | 10,083 | 8,748 | 7,317 | 6,956 |
| Other Income | -1,676 | 2,187 | -8,706 | -2,908 | 1,432 |
| Pre-tax Income | -12,875 | -15,582 | -27,803 | -23,722 | -11,808 |
| Income Tax | -445 | 4,073 | -272 | -124 | 1,309 |
| Net Income Continuous | -12,430 | -19,655 | -27,531 | -23,598 | -13,117 |
| Net Income | $-12,430 | $-19,655 | $-27,531 | $-23,598 | $-13,117 |
| EPS Basic Total Ops | -0.39 | -0.62 | -0.85 | -0.73 | -0.41 |
| EPS Basic Continuous Ops | -0.39 | -0.62 | -0.85 | -0.73 | -0.41 |
| EPS Diluted Total Ops | -0.39 | -0.62 | -0.85 | -0.73 | -0.41 |
| EPS Diluted Continuous Ops | -0.39 | -0.62 | -0.85 | -0.73 | -0.41 |
| EBITDA(a) | $16,035 | $17,218 | $12,884 | $17,997 | $25,412 |